Genexine, Inc. (095700.KQ)
Genexine, Inc., operates as a biotechnology company that focuses on the development and commercialization of immunotherapies in South Korea and internationally.
2,465.00+0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-49.6%
The outlook
Genexine, Inc. currently reads as bearish based on below its 50- & 200-day averages, 6% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Market cap
$112.11B
52-wk high
7,490.00
52-wk low
2,140.00
50-day avg
2,859.80
200-day avg
4,413.70
Trailing P/E
—